Arcoma AB
Stockholm Stock Exchange ARCOMA.ST
Arcoma AB Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD -2.09 M
Arcoma AB Net Cash Used Provided By Financing Activities is USD -2.09 M for the year ending December 31, 2023, a -327.35% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
-
Arcoma AB Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD 921.19 K, a 249.35% change year over year.
-
Arcoma AB Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD 263.69 K, a -80.63% change year over year.
-
Arcoma AB Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD 1.36 M, a 310.57% change year over year.
-
Arcoma AB Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD -646.59 K, a -234.92% change year over year.
Key data
| Date | Net Cash Used Provided By Financing Activities | Dividends Paid | Capital Expenditure | Effect Of Forex Changes On Cash |
|---|
Market news
Loading...
Stockholm Stock Exchange: ARCOMA.ST
| CEO | Mr. Mattias Leire |
| IPO Date | Nov. 14, 2014 |
| Location | Sweden |
| Headquarters | AnnavAegen 1 |
| Employees | 32 |
| Sector | Health Care |
| Industries | |
Description
Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray and radiography systems for radiographic applications, as well as for use in general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. The company sells its products through OEM partners. Arcoma AB was founded in 1990 and is based in Växjö, Sweden.
Key trends
Past 5 years
Similar companies
Genovis AB (publ.)
USD 2.09
-2.04%
Avensia AB (publ)
USD 0.78
6.26%
Stille AB
USD 19.07
4.08%
aXichem AB
USD 0.11
1.48%
StockViz Staff
January 15, 2025
Any question? Send us an email